{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"anchorSlug":"fatal-infantile-hypertonic-myofibrillar-myopathy","columns":[{"gene":"","key":"population-b5dc7e637be6415c5561","label":"Myopathy, myofibrillar, fatal infantile hypertonic, alpha-B crystallin-related","mondoId":"MONDO:0013472","onsetQualifier":null,"originColumnKey":"MONDO:0013472/OMIM:613869","originalViews":[{"key":"MONDO:0013472/OMIM:613869","label":"Myopathy, myofibrillar, fatal infantile hypertonic, alpha-B crystallin-related","scopeLabel":"OMIM:613869","sourceScope":"This column retains the native source entry. It is not a pooled estimate for the umbrella condition."}],"recordKeys":["21704a236025aa49b02759390d8f5e40b320206f3a8eee756652530f1b877eca","68a2e8eabd00db4a021442bde3e16aa80a4d1c69482c927f10933affd3b4edb1","6a399d512da357a9f75a1bc81fc0d11832edb1443882c271a60f76565eafa2a2","6f2774f5a98f54f7356db3cf454e8dd3d566c7dae60b3a4ab7297f40fd8d37a1","9a632efade2e4e6dfaec91505794112960e495cdc11e82c73742883047003da0","d790c6af9a8bf746bff7759f100c3e8a1d2e31e0994a728410714da68475ea9c","d7baf1695036c045f95657ba46dd37011ebb75f6f9da11efd3f762e0c5c4b07a","fb80e11fd416dd1cb6bc09f17e07121adc51b84fe2b5b8fcfc36d70aacb9281b"],"recordQualifiers":{},"scopeLabel":"OMIM:613869","sourceIds":["OMIM:613869"],"sourceScope":"This column retains the native source entry. It is not a pooled estimate for the umbrella condition."}],"comparison":{"collapseColumnsLabel":"Show default populations","defaultColumnKeys":["population-b5dc7e637be6415c5561"],"expandColumnsLabel":"Show all source populations","intro":"Features recorded for this MONDO node. Related-node evidence is available through separately scoped comparisons.","primaryFeatureIds":["HP:0002104","HP:0003236","HP:0001276","HP:0003560","HP:0002878","HP:0002093","HP:0002063"],"scopeNoteHtml":"<p>Each column retains its native condition identifier, assessed population and annotation references. Counts are not pooled.</p>"},"coverage":{"countRecords":4,"emptyColumnKeys":[],"hpoRelease":"2026-06-23","narrativeSourceChanges":[],"records":8,"sourceGroups":{"published":8}},"features":[{"hpoId":"HP:0002104","label":"Apnea","primary":true},{"hpoId":"HP:0003236","label":"Elevated circulating creatine kinase activity","primary":true},{"hpoId":"HP:0001276","label":"Hypertonia","primary":true},{"hpoId":"HP:0003560","label":"Muscular dystrophy","primary":true},{"hpoId":"HP:0002878","label":"Respiratory failure","primary":true},{"hpoId":"HP:0002093","label":"Respiratory insufficiency","primary":true},{"hpoId":"HP:0002063","label":"Rigidity","primary":true},{"hpoId":"HP:0001612","label":"Weak cry","primary":false}],"ledeHtml":"Fatal infantile hypertonic myofibrillar myopathy is a rare, genetic skeletal muscle disease characterized by muscle stiffness and rigidity, hypertonia, weakness, respiratory distress and normal cognition. Patients have persistently elevated creatine kinase and histopathology is typical of myofibrillar myopathy. The manifestation onset follows the short period of normal infantile development and leads to progressive respiratory insufficiency and early death.","mondoId":"MONDO:0013472","node":{"canonicalSlug":"fatal-infantile-hypertonic-myofibrillar-myopathy","comparisons":[{"documentSha256":"26e8997cbe23f89fa826bd098d4292e202c3e47c5fce62b5deca4a568fd1b83d","key":"legacy-myofibrillar-myopathy","kind":"legacy","label":"myofibrillar myopathy","memberIds":["MONDO:0011362","MONDO:0012130","MONDO:0013061","MONDO:0013472","MONDO:0014922","MONDO:0014993","MONDO:0018943","MONDO:0030927","MONDO:0033620","MONDO:0859168"],"mondoId":"MONDO:0018943","url":"https://kcjyutqgtpgteszueluf.supabase.co/storage/v1/object/public/community-guides/learn-data/myofibrillar-myopathy.26e8997cbe23f89fa826bd098d4292e202c3e47c5fce62b5deca4a568fd1b83d.json"},{"documentSha256":"8c5ab84f1ba0262adee39d820f3171ae7532044f1eba679eba9ab07b23179410","key":"expanded-myofibrillar-myopathy","kind":"expanded","label":"myofibrillar myopathy","memberIds":["MONDO:0007294","MONDO:0011076","MONDO:0011362","MONDO:0012130","MONDO:0012215","MONDO:0012277","MONDO:0012289","MONDO:0013061","MONDO:0013472","MONDO:0014922","MONDO:0014993","MONDO:0018943","MONDO:0030927","MONDO:0033620","MONDO:0044647","MONDO:0859168","MONDO:0976133"],"mondoId":"MONDO:0018943","url":"https://kcjyutqgtpgteszueluf.supabase.co/storage/v1/object/public/community-guides/learn-data/node-comparison-8c5ab84f1ba0262adee3.8c5ab84f1ba0262adee39d820f3171ae7532044f1eba679eba9ab07b23179410.json"}],"contexts":[],"lifecycle":"active","narrative":{"causes":[],"contentForm":"summary","independentCorroborationEstablished":false,"matchMethod":"automatic-identity-and-attribution","name":"Fatal infantile hypertonic myofibrillar myopathy","originalSourceId":"ORPHA:280553","paragraphs":["Fatal infantile hypertonic myofibrillar myopathy is a rare, genetic skeletal muscle disease characterized by muscle stiffness and rigidity, hypertonia, weakness, respiratory distress and normal cognition. Patients have persistently elevated creatine kinase and histopathology is typical of myofibrillar myopathy. The manifestation onset follows the short period of normal infantile development and leads to progressive respiratory insufficiency and early death."],"rawAttribution":"ORPHA:280553","reviewed":null,"scope":"exact","source":"GARD","sourceRelease":"2026-10-25T03:42:20Z","upstream":"ORPHA:280553","url":"https://rarediseases.info.nih.gov/diseases/17296"},"ownColumnKeys":["population-b5dc7e637be6415c5561"],"publication":"published","relationships":[{"kind":"parent","label":"myofibrillar myopathy","mondoId":"MONDO:0018943","slug":"myofibrillar-myopathy"}],"schemaVersion":1,"searchIndex":"/node-search/manifest.json","sourceHolds":{},"summaryHolds":[],"translation":"pending"},"records":[{"frequencyKind":"reported","key":"21704a236025aa49b02759390d8f5e40b320206f3a8eee756652530f1b877eca","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"OMIM:613869","disease_name":"Myopathy, myofibrillar, fatal infantile hypertonic, alpha-B crystallin-related","evidence":"PCS","frequency_raw":null,"hpo_id":"HP:0002063","is_excluded":false,"label":"Rigidity","onset_id":null,"reference":"PMID:21337604","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"68a2e8eabd00db4a021442bde3e16aa80a4d1c69482c927f10933affd3b4edb1","raw":{"aspect":"P","body_system":"head_and_neck","disease_id":"OMIM:613869","disease_name":"Myopathy, myofibrillar, fatal infantile hypertonic, alpha-B crystallin-related","evidence":"PCS","frequency_raw":null,"hpo_id":"HP:0001612","is_excluded":false,"label":"Weak cry","onset_id":null,"reference":"PMID:21337604","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"6a399d512da357a9f75a1bc81fc0d11832edb1443882c271a60f76565eafa2a2","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"OMIM:613869","disease_name":"Myopathy, myofibrillar, fatal infantile hypertonic, alpha-B crystallin-related","evidence":"PCS","frequency_raw":null,"hpo_id":"HP:0003560","is_excluded":false,"label":"Muscular dystrophy","onset_id":null,"reference":"PMID:21337604","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"6f2774f5a98f54f7356db3cf454e8dd3d566c7dae60b3a4ab7297f40fd8d37a1","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"OMIM:613869","disease_name":"Myopathy, myofibrillar, fatal infantile hypertonic, alpha-B crystallin-related","evidence":"PCS","frequency_raw":"7/8","hpo_id":"HP:0001276","is_excluded":false,"label":"Hypertonia","onset_id":null,"reference":"PMID:21337604","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"9a632efade2e4e6dfaec91505794112960e495cdc11e82c73742883047003da0","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:613869","disease_name":"Myopathy, myofibrillar, fatal infantile hypertonic, alpha-B crystallin-related","evidence":"PCS","frequency_raw":"4/4","hpo_id":"HP:0003236","is_excluded":false,"label":"Elevated circulating creatine kinase activity","onset_id":null,"reference":"PMID:21337604","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"d790c6af9a8bf746bff7759f100c3e8a1d2e31e0994a728410714da68475ea9c","raw":{"aspect":"P","body_system":"respiratory","disease_id":"OMIM:613869","disease_name":"Myopathy, myofibrillar, fatal infantile hypertonic, alpha-B crystallin-related","evidence":"PCS","frequency_raw":"1/8","hpo_id":"HP:0002104","is_excluded":false,"label":"Apnea","onset_id":null,"reference":"PMID:21337604","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"d7baf1695036c045f95657ba46dd37011ebb75f6f9da11efd3f762e0c5c4b07a","raw":{"aspect":"P","body_system":"respiratory","disease_id":"OMIM:613869","disease_name":"Myopathy, myofibrillar, fatal infantile hypertonic, alpha-B crystallin-related","evidence":"PCS","frequency_raw":"8/8","hpo_id":"HP:0002093","is_excluded":false,"label":"Respiratory insufficiency","onset_id":null,"reference":"PMID:21337604","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"fb80e11fd416dd1cb6bc09f17e07121adc51b84fe2b5b8fcfc36d70aacb9281b","raw":{"aspect":"P","body_system":"respiratory","disease_id":"OMIM:613869","disease_name":"Myopathy, myofibrillar, fatal infantile hypertonic, alpha-B crystallin-related","evidence":"PCS","frequency_raw":null,"hpo_id":"HP:0002878","is_excluded":false,"label":"Respiratory failure","onset_id":null,"reference":"PMID:21337604","source_release":"2026-06-23"},"sourceGroups":["published"]}],"referenceLabels":{},"references":{"causeHtml":"<p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/17296\" rel=\"noreferrer\">GARD</a></p><details class=\"deep-dive\"><summary>Narrative source and scope</summary><dl><dt>Content</dt><dd>summary</dd><dt>Scope</dt><dd>exact</dd><dt>Match method</dt><dd>automatic-identity-and-attribution</dd><dt>Upstream attribution</dt><dd>ORPHA:280553</dd></dl></details>","identityNote":"MONDO identifies this node. Native source populations, annotation references and qualified comparison views retain their original scopes.","importantHtml":""},"sections":[{"bodyHtml":"<p>Fatal infantile hypertonic myofibrillar myopathy is a rare, genetic skeletal muscle disease characterized by muscle stiffness and rigidity, hypertonia, weakness, respiratory distress and normal cognition. Patients have persistently elevated creatine kinase and histopathology is typical of myofibrillar myopathy. The manifestation onset follows the short period of normal infantile development and leads to progressive respiratory insufficiency and early death.</p><p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/17296\" rel=\"noreferrer\">GARD</a></p>","key":"overview","title":"Overview"}],"sharedSources":[],"slug":"fatal-infantile-hypertonic-myofibrillar-myopathy","sourceDocuments":[{"name":"GARD: Fatal infantile hypertonic myofibrillar myopathy","reviewed":null,"source_release":"2026-10-25T03:42:20Z","url":"https://rarediseases.info.nih.gov/diseases/17296"}],"sourceNote":"","synonyms":["fatal infantile hypertonic myofibrillar myopathy"],"takeawayHtml":"","title":"fatal infantile hypertonic myofibrillar myopathy"},"schemaVersion":1}
